Reza Parwaresch

12.5k total citations · 1 hit paper
153 papers, 7.4k citations indexed

About

Reza Parwaresch is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Reza Parwaresch has authored 153 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pathology and Forensic Medicine, 53 papers in Oncology and 41 papers in Molecular Biology. Recurrent topics in Reza Parwaresch's work include Lymphoma Diagnosis and Treatment (58 papers), Viral-associated cancers and disorders (20 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Reza Parwaresch is often cited by papers focused on Lymphoma Diagnosis and Treatment (58 papers), Viral-associated cancers and disorders (20 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Reza Parwaresch collaborates with scholars based in Germany, United States and Austria. Reza Parwaresch's co-authors include Markus Tiemann, Pierre Rudolph, Alfred Reiter, Martin Schrappe, Wolfram Klapper, Klaus Heidorn, Guido Krupp, D. Harms, H J Heidebrecht and Matthias Krams and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Reza Parwaresch

152 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria and classification of mastocytosis: a consensus proposal

2001 738 citations Reza Parwaresch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reza Parwaresch Germany	46	2.8k	2.5k	2.0k	1.6k	945	153	7.4k
Berthold Streubel Austria	45	2.8k 1.0×	1.9k 0.8×	1.7k 0.8×	945 0.6×	880 0.9×	149	6.5k
Laurence Lamant France	45	4.4k 1.6×	3.3k 1.3×	1.9k 1.0×	1.5k 1.0×	1.5k 1.6×	203	7.9k
Gunhild Mechtersheimer Germany	41	1.4k 0.5×	2.5k 1.0×	1.8k 0.9×	1.0k 0.6×	2.4k 2.5×	193	6.7k
Leonhard Müllauer Austria	39	1.3k 0.5×	1.3k 0.5×	1.8k 0.9×	1.2k 0.7×	592 0.6×	198	5.3k
Jeffrey Sklar United States	47	3.3k 1.2×	2.5k 1.0×	4.8k 2.4×	2.3k 1.5×	645 0.7×	87	10.4k
Alessandro M. Gianni Italy	44	3.1k 1.1×	3.7k 1.5×	2.1k 1.0×	2.1k 1.3×	922 1.0×	205	9.4k
Ulrich Dührsen Germany	51	3.3k 1.2×	3.0k 1.2×	2.2k 1.1×	3.2k 2.1×	788 0.8×	283	10.3k
Jan Delabie Norway	48	4.7k 1.7×	3.2k 1.3×	1.4k 0.7×	1.7k 1.1×	563 0.6×	201	7.0k
Azra H. Ligon United States	40	2.7k 1.0×	4.9k 1.9×	4.5k 2.2×	2.2k 1.4×	1.8k 1.9×	89	11.5k
Masao Seto Japan	47	3.3k 1.2×	2.6k 1.0×	3.6k 1.8×	2.1k 1.4×	675 0.7×	239	8.5k

Countries citing papers authored by Reza Parwaresch

Since Specialization

Citations

This map shows the geographic impact of Reza Parwaresch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Parwaresch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Parwaresch more than expected).

Fields of papers citing papers by Reza Parwaresch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Parwaresch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Parwaresch. The network helps show where Reza Parwaresch may publish in the future.

Co-authorship network of co-authors of Reza Parwaresch

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Parwaresch. A scholar is included among the top collaborators of Reza Parwaresch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Parwaresch. Reza Parwaresch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oschlies, Ilske, Wolfram Klapper, Martin Zimmermann, et al.. (2006). Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood. 107(10). 4047–4052. 112 indexed citations

Schrader, Carsten, Dirk Janssen, P. Meusers, et al.. (2005). Repp86: a new prognostic marker in mantle cell lymphoma. European Journal Of Haematology. 75(6). 498–504. 17 indexed citations

Krams, Matthias, Barbara Hero, Frank Berthold, et al.. (2003). Full-Length Telomerase Reverse Transcriptase Messenger RNA Is an Independent Prognostic Factor in Neuroblastoma. American Journal Of Pathology. 162(3). 1019–1026. 38 indexed citations

Klapper, Wolfram, Matthias Krams, Wenbin Qian, Dirk Janssen, & Reza Parwaresch. (2003). Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. British Journal of Cancer. 89(4). 713–719. 43 indexed citations

Nizze, H, et al.. (2003). Prim�re renale Manifestation bei malignen Lymphomen und Leuk�mie. Der Pathologe. 24(6). 460–465. 2 indexed citations

Huebner, Angela, et al.. (2001). Temporary Response of Localized Intracranial Mast Cell Sarcoma to Combination Chemotherapy. The American journal of pediatric hematology/oncology. 23(2). 134–138. 28 indexed citations

Miettinen, Helena E., Tero A.H. Järvinen, Udo Kellner, et al.. (2000). High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas. Neuropathology and Applied Neurobiology. 26(6). 504–512. 37 indexed citations

Kellner, Udo, Holger A. Haenssle, Pierre Rudolph, & Reza Parwaresch. (2000). Detection of four new single-stranded telomeric DNA binding proteins by means of an optimized protein blotting procedure. Pathology - Research and Practice. 196(12). 801–806. 2 indexed citations

Schlegelberger, Brigitte, et al.. (1999). Assignment<footref rid="foot01"><sup>1</sup></footref> of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization. Cytogenetic and Genome Research. 84(3-4). 182–183. 17 indexed citations

10.

Rudolph, Pierre, Håkan Olsson, G. Bonatz, et al.. (1999). Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. The Journal of Pathology. 187(2). 207–216. 93 indexed citations

11.

Rudolph, Pierre, Christoph Schubert, Bettina Zelger, Bernhard Zelger, & Reza Parwaresch. (1999). Differential Expression of CD34 and Ki-M1p in Pleomorphic Fibroma and Dermatofibroma With Monster Cells. American Journal of Dermatopathology. 21(5). 414–414. 22 indexed citations

12.

Rudolph, Pierre, et al.. (1998). Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens. Human Pathology. 29(11). 1216–1222. 65 indexed citations

13.

Mettler, Liselotte, et al.. (1996). Proliferative activity of the endometrium throughout the menstrual cycle in infertile women with and without endometriosis. Fertility and Sterility. 66(3). 369–375. 30 indexed citations

14.

Heidebrecht, H J, Friedrich Buck, Karen M. Haas, Hans Wacker, & Reza Parwaresch. (1996). Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteins. Cell Proliferation. 29(7). 413–425. 80 indexed citations

15.

Menke, Martin A. O. H., et al.. (1995). Temperature gradient gel electrophoresis for analysis of a polymerase chain reaction‐based diagnostic clonality assay in the early stages of cutaneous T‐cell lymphomas. Electrophoresis. 16(1). 733–738. 30 indexed citations

16.

Claviez, Alexander, Markus Tiemann, J. H. Peters, et al.. (1994). The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood. Annals of Hematology. 68(2). 61–66. 26 indexed citations

17.

Reiter, Alfred, Markus Tiemann, W.-D. Ludwig, et al.. (1994). Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 1: Klassifikation und Einteilung in strategische Therapiegruppen. Klinische Pädiatrie. 206(4). 222–233. 17 indexed citations

18.

Reiter, Alfred, Martin Schrappe, Markus Tiemann, et al.. (1994). Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.. Journal of Clinical Oncology. 12(5). 899–908. 155 indexed citations

19.

Kreipe, Hans, Henning Feist, Laurice K. Fischer, et al.. (1993). Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.. PubMed. 53(8). 1956–61. 62 indexed citations

20.

Kreipe, Hans, et al.. (1991). Increased Methylation of the <i>c-fms</i>Protooncogene in Acute Myelomonocytic Leukemias. Pathobiology. 59(4). 293–298. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact